Aerie Pharmaceuticals (United States)
Aerie Pharmaceuticals was an American clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Aerie Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
55%
Total
Publications
64
Total Open
Publications
35
Total
Citations
3.3K
Open Access
Percentage
55%
Total
Publications
64
Total Open
Publications
35
Total
Citations
3.3K
Breakdown
Publisher Open
14%
Both
30%
Other Platform Open
11%
Closed
45%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 25%
7
Hybrid 54%
15
No Guarantees 21%
6
Other Platform Open
Domain 69%
18
Other Internet 27%
7
Institution 12%
3
Preprint 8%
2
Public 4%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 18 |
DOI | Other Internet | 7 |
Imperial College London | Institution | 2 |
bioRxiv | Preprint | 2 |
King's College London | Institution | 1 |
Figshare | Public | 1 |
Europe PMC | Domain | 1 |